- Home
- GORV vs LSTA Comparison
GORV vs LSTA Comparison
Compare GORV & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- LSTA
- Stock Information
- Founded
- GORV 1976
- LSTA 1980
- Country
- GORV United States
- LSTA United States
- Employees
- GORV N/A
- LSTA N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- LSTA Misc Health and Biotechnology Services
- Sector
- GORV Consumer Discretionary
- LSTA Health Care
- Exchange
- GORV Nasdaq
- LSTA Nasdaq
- Market Cap
- GORV 25.3M
- LSTA 25.1M
- IPO Year
- GORV 2015
- LSTA N/A
- Fundamental
- Price
- GORV $4.32
- LSTA $2.74
- Analyst Decision
- GORV Hold
- LSTA Strong Buy
- Analyst Count
- GORV 2
- LSTA 2
- Target Price
- GORV $60.00
- LSTA $23.50
- AVG Volume (30 Days)
- GORV 38.4K
- LSTA 63.0K
- Earning Date
- GORV 08-19-2025
- LSTA 08-07-2025
- Dividend Yield
- GORV N/A
- LSTA N/A
- EPS Growth
- GORV N/A
- LSTA N/A
- EPS
- GORV N/A
- LSTA N/A
- Revenue
- GORV $767,257,000.00
- LSTA $1,070,000.00
- Revenue This Year
- GORV $15.65
- LSTA N/A
- Revenue Next Year
- GORV $20.54
- LSTA N/A
- P/E Ratio
- GORV N/A
- LSTA N/A
- Revenue Growth
- GORV N/A
- LSTA N/A
- 52 Week Low
- GORV $3.83
- LSTA $1.87
- 52 Week High
- GORV $77.07
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- GORV 28.97
- LSTA 55.49
- Support Level
- GORV $3.83
- LSTA $2.55
- Resistance Level
- GORV $5.49
- LSTA $2.87
- Average True Range (ATR)
- GORV 0.50
- LSTA 0.20
- MACD
- GORV -0.18
- LSTA 0.02
- Stochastic Oscillator
- GORV 5.06
- LSTA 58.06
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.